Ji-Quan Wang

Suggest Changes
Learn More
BACKGROUND We designed this randomized controlled trial (RCT) to assess whether lobaplatin-based concurrent chemotherapy might be superior to cisplatin-based concurrent chemotherapy for FIGO stage II(More)
  • 1